December 9, 2009 — A feasibility clinical trial was launched last week to evaluate the safety and efficacy of a combined surgical and catheter procedure, the convergent procedure, for the treatment of symptomatic paroxysmal atrial fibrillation (AF).

December 9, 2009 - An expert panel reviewing Canadian medical isotope productions selected electron beam technology as a superior approach to accelerator-based isotope production.

The panel has recommended the Canadian government make an investment in linear accelerator (linac) technology to address the country’s shrinking isotope supply.

December 8, 2009 – New findings indicate reduced heart rate recovery in combination with heightened T-wave alternans is a powerful predictor of cardiovascular and all-cause death in low-risk populations.

December 9, 2009 – Of the 1,200 cardiologists and cardiovascular ultrasound technicians recently surveyed, 87 percent said the new 2010 CMS Physician Fee Schedule (PFS) could force them to stop accepting Medicare patients, reduce staff or shut down their practice completely.

December 9, 2009 – Research published in the December issue of The Journal of Nuclear Medicine (JNM) suggests SPECT, when combined with low-dose CT, may provide an accurate diagnosis for pulmonary embolism.

December 8, 2009 – The Cleveland Clinic Heart and Vascular Institute is constructing a new cardiovascular building on its main campus to develop and commercialize cardiovascular technology.

December 8, 2009 – The first live U.K. cases involving Cappella’s self-expanding Sideguard Coronary Sidebranch Stent and delivery system were recently performed at PCI Live 2009 with the second case following immediately thereafter, off-camera.

December 8, 2009 – The U.S. Food and Drug Administration (FDA) yesterday issued recommendations to lower radiation exposure during CT perfusion scans, after it discovered more cases of overexposure.

December 8, 2009 – An updated version of RIS/PACS, showcased last week at RSNA 2009, includes solutions for PET/CT and SPECT/CT fusion, and nuclear cardiology.

December 8, 2009 – The U.S. Food and Drug Administration (FDA) gave 510(k) clearance last week for Spectranetics’ new VisiSheath Dilator Sheath for pacing and defibrillator lead removal. The sheath can be used alone or as an enhanced outer support sheath in conjunction with compatible inner sheaths such as Spectranetics’ Laser Sheath (SLS II).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now